Please note

Due to the recent spike in Covid-19 cases, we are no longer able to entertain walk-in visits to our headquarters or any of our facilities.

Deculin 15mg tablets

Dexa Medica

Ingredients in every tablet

Pioglitazone 15 mg

Each package contains

5 strips of 6 tablets

Dosage form

tablet

Dosage formTablet; plain

Flavour

None

W.H.O. classification

A10B
A10B

A.T.C. Level 1

Anatomical Main group

A - Alimentary tract and metabolism
A10B

A.T.C. Level 2

Therapeutic subgroup

A10 - Drugs Used in Diabetes
A10B

A.T.C. Level 3

Pharmacological subgroup

A10B - Blood Glucose Lowering Drugs; excl. Insulins

Available in

Indonesia

Warnings

Alcohol

CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Machinery

CAUTIONThis item may not be safe for use while operating heavy machinery. Use with caution and after consultation with your doctor.

Pregnancy

NOT RECOMMENDEDThis item is not safe for use during pregnancy.

Lactation

NOT RECOMMENDEDThis item is not safe for use during lactation.

Indication

Combination therapy
Deculin is indicated as a combination therapy with sulfonylurea or metformin in patients with type-2 diabetes mellitus who are inadequately controlled on sulfonylurea and metformin monotherapy.

Dosage

0 TO 18 YEARS OLD
No data are available of pioglitazone in children and adolescents under 18 years of age, therefore pioglitazone should not be used for that patients.

18 TO 65 YEARS OLD
— Combination with metformin:
15-30 mg once daily. The current metformin dose can be continued upon initiation of pioglitazone therapy.

— Combination with sulfonylurea:
15-30 mg once daily. The current sulfonylurea dose can be continued upon initiation of pioglitazone therapy. If hypoglycemia occurs, the dose of the sulfonylurea should be decreased. If hypoglycemia occurs, the dose of the sulfonylurea should be decreased.

65 YEARS OLD AND ABOVE
No dose adjustment is necessary for elderly patients.

ADMINISTRATION
Should be taken once daily with or without food.

PATIENTS WITH IMPAIRED RENAL FUNCTION
No dose adjustment is necessary in patients with renal failure (creatinine clearance >4 ml/minute).

PATIENTS WITH IMPAIRED HEPATIC FUNCTION
Pioglitazone should not be used in patients with hepatic impairment.